Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial

Adrien Grancher, Matteo Landi, Alexej Ballhausen, Rosario Vidal Tocino, Annabel Alig, Ada Taravella, Karine Le Malicot, Emilie Soularue, Claire Gallois, Meriem Guarssifi, Manon Pelkowski, Marta Beltran, Lisa Kochen, Laura Delliponti, Julien Taïeb, Javier Sastre, Dominik Paul Modest, Chiara Cremolini, Thibault Mazard, David Tougeron

Open source

DOI: 10.1016/j.dld.2026.04.009
Published: 2026-07
Container: Digestive and Liver Disease
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.dld.2026.04.009,
  title = {Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial},
  author = {Adrien Grancher and Matteo Landi and Alexej Ballhausen and Rosario Vidal Tocino and Annabel Alig and Ada Taravella and Karine Le Malicot and Emilie Soularue and Claire Gallois and Meriem Guarssifi and Manon Pelkowski and Marta Beltran and Lisa Kochen and Laura Delliponti and Julien Taïeb and Javier Sastre and Dominik Paul Modest and Chiara Cremolini and Thibault Mazard and David Tougeron},
  year = {2026},
  journal = {Digestive and Liver Disease},
  doi = {10.1016/j.dld.2026.04.009},
  url = {https://doi.org/10.1016/j.dld.2026.04.009}
}

RIS

TY  - JOUR
TI  - Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial
AU  - Adrien Grancher
AU  - Matteo Landi
AU  - Alexej Ballhausen
AU  - Rosario Vidal Tocino
AU  - Annabel Alig
AU  - Ada Taravella
AU  - Karine Le Malicot
AU  - Emilie Soularue
AU  - Claire Gallois
AU  - Meriem Guarssifi
AU  - Manon Pelkowski
AU  - Marta Beltran
AU  - Lisa Kochen
AU  - Laura Delliponti
AU  - Julien Taïeb
AU  - Javier Sastre
AU  - Dominik Paul Modest
AU  - Chiara Cremolini
AU  - Thibault Mazard
AU  - David Tougeron
PY  - 2026
JO  - Digestive and Liver Disease
DO  - 10.1016/j.dld.2026.04.009
UR  - https://doi.org/10.1016/j.dld.2026.04.009
ER  -

APA

Grancher, A., Landi, M., Ballhausen, A., Tocino, R. V., Alig, A., Taravella, A., Malicot, K. L., Soularue, E., Gallois, C., Guarssifi, M., Pelkowski, M., Beltran, M., Kochen, L., Delliponti, L., Taïeb, J., Sastre, J., Modest, D. P., Cremolini, C., Mazard, T., & Tougeron, D. (2026). Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.04.009

Source records

crossref · retrieved 2026-11-10T11:43:27.601Z